Ciphergen s Revenues Down, Losses Narrowed During Q2

Jul 30, 2004

NEW YORK, July 30 (GenomeWeb News) - Ciphergen Biosystems yesterday reported sliding revenues and narrowed losses for the second quarter.

The company booked $10.8 million in revenues for the quarter, down from $14.3 million during the same quarter in 2003.

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.